The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,875.00
Bid: 2,873.00
Ask: 2,874.00
Change: -4.00 (-0.14%)
Spread: 1.00 (0.035%)
Open: 2,887.00
High: 2,897.00
Low: 2,864.00
Prev. Close: 2,879.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DTR 6.3.5

29 May 2020 10:37

RNS Number : 3776O
3i Group PLC
29 May 2020
 

3i Group plc - D.T.R. 6.3.5

 

The purpose of this announcement is to release certain regulated information in unedited full text to meet the requirements of Disclosure and Transparency Rule 6.3.5.

 

The information below is an extract from the 3i Group plc Annual report 2020:

 

"In accordance with the FCA's Disclosure and Transparency Rules, the Directors confirm to the best of their knowledge that:

 

(a) the financial statements, prepared in accordance with applicable accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole; and

 

(b) the Strategic report includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole together with a description of the principal risks and uncertainties that they face."

 

The Directors of the Company and their functions are as set out below:

 

S R Thompson, Chairman

S A Borrows, Chief Executive

J S Wilson, Group Finance Director

J P Asquith, Non-executive Director

C J Banszky, Non-executive Director

S W Daintith, Non-executive Director

P Grosch, Non-executive Director

D A M Hutchison, Non-executive Director

C L McConville, Non-executive Director

A Schaapveld, Non-executive Director

 

Other regulated information in the Annual report 2020 of a type that would be required to be disseminated in a half-yearly report has already been released in unedited full text via the announcement of results made at 7:00 a.m. on 14 May 2020 (RNS number 8396M).

 

Copies of the Annual report 2020 and Notice of AGM are also available via the 3i website at www.3i.com.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUKOKRRVUVURR
Date   Source Headline
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding
12th Jun 20174:48 pmRNSBlock listing Interim Review
2nd Jun 201711:16 amRNSDirector/PDMR Shareholding
31st May 20174:25 pmRNSTotal Voting Rights
31st May 20174:21 pmRNSDirector/PDMR Shareholding
31st May 201710:12 amRNSDoc re. 2017 Annual Report and Accounts
30th May 20178:30 amRNSPrivate Equity Capital Markets Seminar
18th May 20172:49 pmRNSDirector/PDMR Shareholding
18th May 20179:41 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSResults for the year to 31 March 2017
28th Apr 20173:05 pmRNSTotal Voting Rights
28th Apr 20173:05 pmRNSDirector/PDMR Shareholding
6th Apr 201711:37 amRNSPortfolio Update
6th Apr 201710:47 amRNSDirector Declaration
31st Mar 20171:50 pmRNSTotal Voting Rights
31st Mar 20171:50 pmRNSDirector/PDMR Shareholding
6th Mar 20179:45 amRNSDirector/PDMR Shareholding
3rd Mar 201710:00 amRNSCompletion of sale of 3i Debt Management
28th Feb 20172:30 pmRNSTotal Voting Rights
28th Feb 20172:26 pmRNSDirector/PDMR Shareholding
31st Jan 20174:21 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.